BiotechTube
Home/Contineum Therapeutics/Dr. Carmine Stengone
DC

Dr. Carmine Stengone

President & Chief Executive Officer

Contineum Therapeutics

Therapeutic Areas

NeuroscienceImmunologyInflammation

Contineum Therapeutics Pipeline

DrugIndicationPhase
PIPE-307Relapsing Remitting Multiple SclerosisPhase 2
PIPE-791Idiopathic Pulmonary FibrosisPhase 1
PIPE-505UndisclosedPreclinical

Leadership Team at Contineum Therapeutics

DM
Dr. Mark McDonnell
Chief Scientific Officer
DS
Dr. Srinivas Rao
Chief Medical Officer
VC
Vickie Capps
Chief Financial Officer
View full Contineum Therapeutics profile